Ernie J. Garateix, Chief Executive Officer of Heritage Insurance Holdings, Inc. (NASDAQ: HRTG), disposed of common shares totaling $229,652 on April 20, 2026. The block consisted of 8,334 shares sold at per-share prices ranging from $27.5245 to $28.4032.
The disposition was carried out under a pre-established Rule 10b5-1 trading arrangement that the company said was adopted on June 13, 2025. After completing these transactions, Garateix retains direct ownership of 1,060,955 shares of Heritage Insurance common stock.
At the time of the sale, Heritage Insurance shares were trading at $26.90, representing an increase of nearly 46% over the prior 12 months. Independent valuation coverage referenced in InvestingPro analysis describes the stock as appearing undervalued on a Fair Value basis, and highlights a notably low price-to-earnings ratio of 4.3. Investors are directed to a Pro Research Report covering HRTG and more than 1,400 US equities for additional detail.
Separate company developments provide context for the insider sale. Heritage Insurance reported fourth-quarter results that exceeded analyst expectations, a performance attributed to improvements in underwriting and a reduction in catastrophe-related losses. Those operational improvements were cited alongside a range of analyst responses.
Truist Securities raised its price target on Heritage Insurance to $39 from $37 while maintaining a Buy rating. In the same update Truist increased its 2026 earnings-per-share estimate to $5.00 from $4.50 and provided a 2027 EPS forecast of $5.55.
Piper Sandler reiterated an Overweight designation for the insurer ahead of Heritage's upcoming fourth-quarter 2025 earnings report and named the company its focus idea for the week. Meanwhile, Citizens kept a Market Perform rating, noting that excess capital is accumulating on Heritage's balance sheet and that this capital could support further growth initiatives.
Citizens' commentary also highlighted a decline in the net written premium-to-equity ratio, which has fallen below 2.0x. The firm interprets that metric as evidence of excess capital, a condition that may influence how the company chooses to deploy resources going forward.
The factual record available here is limited to the items reported: the CEO's sale under a Rule 10b5-1 plan and the company's recent quarter-to-quarter operational and capital metrics, along with the analyst actions described. The article does not attempt to attribute causes or project future results beyond the specific analyst forecasts and company disclosures noted above.